BIOMAT Database Logo BIOMAT Database Logo

Cefotiam during continuous haemofiltration. 1993

J Evers, and K Borner, and P Koeppe

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D015310 Cefotiam One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms. Abbott-48999,CGP-14221-E,Cefotiam Hydrochloride,Ceradolan,Haloapor,Halospor,SCE-963,Abbott 48999,Abbott48999,CGP 14221 E,CGP14221E,Hydrochloride, Cefotiam,SCE 963,SCE963

Related Publications

J Evers, and K Borner, and P Koeppe
Clinical pharmacokinetics during continuous haemofiltration.
June 1994, Clinical pharmacokinetics,
J Evers, and K Borner, and P Koeppe
Drug treatment during continuous haemofiltration.
January 1994, Intensive care medicine,
J Evers, and K Borner, and P Koeppe
Acute hypotension during continuous arteriovenous haemofiltration.
May 1990, Pediatric nephrology (Berlin, Germany),
J Evers, and K Borner, and P Koeppe
Ceftriaxone pharmacokinetics during continuous arteriovenous haemofiltration.
March 1991, The Journal of antimicrobial chemotherapy,
J Evers, and K Borner, and P Koeppe
Heparin-induced thrombocytopenia during continuous haemofiltration.
January 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J Evers, and K Borner, and P Koeppe
Heparin clearance during continuous veno-venous haemofiltration.
January 1994, Intensive care medicine,
J Evers, and K Borner, and P Koeppe
DC cardioversion during continuous veno-venous haemofiltration.
February 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J Evers, and K Borner, and P Koeppe
Management of sodium disorders during continuous haemofiltration.
January 2010, Critical care (London, England),
J Evers, and K Borner, and P Koeppe
On continuous haemofiltration.
January 1991, Intensive care medicine,
J Evers, and K Borner, and P Koeppe
Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration.
January 2007, Nursing in critical care,
Copied contents to your clipboard!